Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
Cantargia
Cantargia to Host Q2 2026 Interim Results Conference Call
August 4, 2026
Cantargia Announces Changes in Number of Shares and Votes
July 31, 2026
Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC
June 26, 2026
Cantargia and H.C. Wainwright to Host KOL Call on The Case for Nadunolimab in PDAC
June 11, 2026
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
June 10, 2026